摘要
目的了解下呼吸道不动杆菌感染的临床特征及耐药分析。方法对52例下呼吸道不动杆菌感染患者的临床特征、病原菌的构成、药敏结果进行分析。结果下呼吸道不动杆菌感染患者均有较严重的基础性疾病。多数患者免疫力低下,年龄较大,住院时间较长。药敏试验表明头孢哌酮/舒巴坦敏感率达到86.5%,其次为左旋氧氟沙星、替卡西林/克拉唯酸、亚胺培南、环丙沙星、头孢吡啶、头孢他啶也有相当敏感,而头孢曲松、氨曲南、庆大霉素、头孢噻肟、复方新诺明等常用抗菌素耐药率高。结论治疗临床疑是不动杆菌感染时,必须尽快做细菌培养及药敏试验,尽量减少经验性用药,才能更有效控制该菌所致各种感染。
Objective To investigate the clinical characteristic of 52 patients with lower respiratory tract infection by acinetobacter and their drug-resistance analysis. Methods The clinical data of 52 cases of lower respiratory tract infection by acinetobacter and their drug-susceptibility were analyzed. Result A total of 52 patients with lower respiratory tract infection by acinetobacte suffered from underly diseases. Some of them were senile patients, application of multiple antibiotics, host immune suppression and longtime in- patient. Cefoperazone/sulbactam was the first choice for treating acinetobacter infection, then levofloxacin、Imipenem, Ticarcillin/clavulanic acid. Conclusion It is suggested that there be urgent need for surveillance of bacterial resistance and reasonable use of antibiotics, which can reduce or control lower respiratory tract infection by acinetobacter.
出处
《国际医药卫生导报》
2005年第8期19-20,共2页
International Medicine and Health Guidance News
关键词
不动杆菌
下呼吸道感染
临床特征药敏试验
Acinetobacter Lower respiratory tract infection Clinical characteristic Drug-resistance analysis
